[HTML][HTML] Persistent SARS-CoV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID

A Vojdani, E Vojdani, E Saidara, M Maes - Viruses, 2023 - mdpi.com
A novel syndrome called long-haul COVID or long COVID is increasingly recognized in a
significant percentage of individuals within a few months after infection with SARS-CoV-2 …

[HTML][HTML] Long COVID: a review and proposed visualization of the complexity of long COVID

R Perumal, L Shunmugam, K Naidoo… - Frontiers in …, 2023 - frontiersin.org
Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus–2 (SARS-CoV-2)
infection, or Long COVID, is a prevailing second pandemic with nearly 100 million affected …

[HTML][HTML] A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with …

C Kedor, H Freitag, L Meyer-Arndt, K Wittke… - Nature …, 2022 - nature.com
A subset of patients has long-lasting symptoms after mild to moderate Coronavirus disease
2019 (COVID-19). In a prospective observational cohort study, we analyze clinical and …

[HTML][HTML] Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms

K Son, R Jamil, A Chowdhury… - European …, 2023 - Eur Respiratory Soc
Background Autoimmunity has been reported in patients with severe coronavirus disease
2019 (COVID-19). We investigated whether anti-nuclear/extractable-nuclear antibodies …

[HTML][HTML] Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may …

A Kruger, M Vlok, S Turner, C Venter… - Cardiovascular …, 2022 - Springer
Background Post-acute sequelae of COVID-19 (PASC), also now known as long COVID,
has become a major global health and economic burden. Previously, we provided evidence …

[HTML][HTML] Dysregulated autoantibodies targeting vaso-and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity

F Sotzny, IS Filgueiras, C Kedor, H Freitag… - Frontiers in …, 2022 - frontiersin.org
Most patients with Post COVID Syndrome (PCS) present with a plethora of symptoms without
clear evidence of organ dysfunction. A subset of them fulfills diagnostic criteria of myalgic …

[HTML][HTML] Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study

F Tesch, F Ehm, A Vivirito, D Wende, M Batram… - Clinical …, 2023 - Springer
Objectives To investigate whether the risk of developing an incident autoimmune disease is
increased in patients with prior COVID-19 disease compared to those without COVID-19, a …

The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and …

DB Kell, E Pretorius - Biochemical Journal, 2022 - portlandpress.com
Ischaemia–reperfusion (I–R) injury, initiated via bursts of reactive oxygen species produced
during the reoxygenation phase following hypoxia, is well known in a variety of acute …

Molecular mimicry and autoimmunity in the time of COVID-19

M Rojas, M Herrán, C Ramírez-Santana… - Journal of …, 2023 - Elsevier
Infectious diseases are commonly implicated as potential initiators of autoimmune diseases
(ADs) and represent the most commonly known factor in the development of autoimmunity in …

[HTML][HTML] Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease

I Busnadiego, IA Abela, PM Frey, DA Hofmaenner… - PLoS …, 2022 - journals.plos.org
Autoantibodies neutralizing the antiviral action of type I interferons (IFNs) have been
associated with predisposition to severe Coronavirus Disease 2019 (COVID-19). Here, we …